Why Can a 99% Pure Chemical Still Fail in Production?
A chemical can meet a stated purity of 99% and still fail in a sensitive production process. This article explains how impurity profiles, analytical methods, application-specific specifications and qualified second sources help identify and control the real quality risk.
How to Transfer a Chemical Synthesis Process to GMP Manufacturing
Moving an API route from laboratory development to GMP manufacture is a controlled handover, not a simple scale-up. This guide explains the GMP boundary, stage gates, transfer package, roles, risks and readiness criteria.
How to Verify the Commercial Availability of a Chemical Compound
A chemical compound can appear in databases and supplier catalogues without being practically available for a specific project. This guide explains how R&D and procurement teams can evaluate identity, stock, specification, analytical evidence, application suitability and recurring supply.
What Are Stable-Isotope-Labelled Reference Compounds and When Is Custom Synthesis Required?
Stable-isotope-labelled reference compounds support reliable quantitative analysis by closely tracking the behaviour of the target analyte. This guide explains how they work, which quality criteria matter and when custom synthesis becomes necessary.
How Custom Chemical Synthesis Supports Parasite Research
Parasite research often depends on molecules that are not commercially available. Learn how custom synthesis, analytical standards and isotope-labelled compounds turn biological observations into testable scientific hypotheses.
Why Employee-Oriented Companies Are More Successful in Chemical Custom Synthesis
Modern chemical research depends on far more than advanced laboratories and analytical technologies. Employee-oriented leadership, scientific collaboration, and long-term knowledge retention are becoming key competitive advantages in Chemical Custom Synthesis, Contract Research, and Process Development.
From Stadium to Lab: The Molecule Hiding in Plain Sight
What does a football have in common with cutting-edge chemistry? More than you might think. The iconic pattern of pentagons and hexagons mirrors the molecular structure of Buckminsterfullerene (C60), one of the most fascinating carbon nanomaterials. This article explores why fullerenes are gaining renewed attention in functional materials, organic electronics, nanotechnology, and sustainable innovation. It also examines the real industrial challenge: not the synthesis of C60 itself, but the scalable, reproducible, and regulatory-compliant functionalization of fullerene derivatives. Discover how custom synthesis, process chemistry, and route optimization are transforming promising laboratory concepts into practical industrial solutions.
Networking as a chemical CRO: bold focus, full service or kind of King Lear?
Should a chemical CRO try to solve every customer challenge—or focus on its core expertise? This article explores the balance between specialization and networking in chemical contract research. Using real customer examples, it discusses why honesty, scientific expertise, and strategic partnerships often create more value than attempting to provide every answer in-house. Learn how focused custom synthesis, supported by trusted chemical networks such as 4Synth, enables access to complementary technologies, regulatory expertise, and scalable solutions while maintaining scientific excellence. Discover why successful chemical CROs are defined not by the size of their network, but by knowing when to collaborate and when to stay true to their core competencies.
Have you experienced problems with distinguishing between CMOs and CDMOs and finally (chemical) CROs or CRDMOs?
25 Years in Chemical Custom Synthesis: Why Customers Still Confuse CROs, CMOs and CDMOs As a manager of a smaller (chemical custom) synthesis company I have been dealing with this issue for more than 25 years. From my experience, there is even more uncertainty about this question now than decades ago. So, our sales team […]
From Molecules to Markets: Where Fine Organic Synthesis becomes real value
What happens when a cluster of excellence for synthesis brings together the right minds, technologies, and ideas? “You don’t just talk about innovation – you actively create value by transforming matter.” At this year’s 4Synth Annual Meeting (March 2026), more than 30 experts from industry and research gathered at the Fraunhofer Center for Chemical-Biotechnological Processes […]